Lyn Fitzgerald on the Adoption of Risk-Based Models

I’m not quite certain that the system is equipped to provide a comfort level for clinicians that they’re ready to take on two-sided risk, explained Lyn Fitzgerald, senior vice president, US & Global Development at the National Comprehensive Cancer Network (NCCN).

Transcript:

Do you think there should be greater adoption of risk-based models, and if so, why?

So, I went and looked at that study and there was [I believe] 23% increase over the past 2 years so there is a growth rate relative to adoption of alternative payment models. But relative to risk, the question is preparedness. Just listening to the discussion today, I’m not quite certain that the system is equipped to provide a comfort level for clinicians that they’re ready to take on two-sided risk.

For example, something that was published in your journal, I think it was in April [by] David Nash from Jefferson I believe, talked about why providers were not willing to take 2-sided risk and it was that they felt that they did not have control over variation and quality within the system, but also that their lack of control was overestimated. I believe that that has to do with a lack of infrastructure, so the technology is not there, the data, the feedback around medical information and claims information, to allow a practice or a health system to prepare may not be there in the broader scheme for there to be wider adoption more than the pace that we’re moving at now.